Works matching IS 10781552 AND DT 2017 AND VI 23 AND IP 5

Results: 11

Miracle drug: Brazil approves never-tested cancer medicine.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 399, doi. 10.1177/1078155216665246

By:

Kuchenbecker, Ricardo S.;
Mota, Daniel M.

Publication type:

Article

Levetiracetam for the prevention of busulfan-induced seizures in pediatric hematopoietic cell transplantation recipients.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 344, doi. 10.1177/1078155216651128

By:

Floeter, Abby E.;
McCune, Jeannine S.

Publication type:

Article

Rationalizing the use of auxiliary label for oral oncology drugs.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 338, doi. 10.1177/1078155216650986

By:

Ng, Tonya;
Badry, Nadine;
de Lemos, Mário L.

Publication type:

Article

5-fluorouracil toxicity in the treatment of colon cancer associated with the genetic polymorphism 2846 A>G (rs67376798).

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 396, doi. 10.1177/1078155216647202

By:

González-Perera, Itamar;
Gutiérrez-Nicolás, Fernando;
Nazco-Casariego, Gloria J.;
Ramos-Díaz, Ruth;
Hernández-San Gil, Raquel;
Pérez-Pérez, José A.;
González García, Jonathan;
González De La Fuente, Guillermo A.

Publication type:

Article

Single 4.5 mg fixed-dose of rasburicase for hyperuricemia associated with tumor lysis syndrome.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 333, doi. 10.1177/1078155216644975

By:

Patel, Kajal S.;
Lau, Jessica E.;
Zembillas, Anthony S.;
Gallagher, Erika M.

Publication type:

Article

Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 323, doi. 10.1177/1078155216643860

By:

Poupeau, Céline;
Tanguay, Cynthia;
Plante, Caroline;
Gagné, Sébastien;
Caron, Nicolas;
Bussières, Jean-François

Publication type:

Article

Docetaxel-induced pericardial effusion.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 389, doi. 10.1177/1078155216643859

By:

Dogan, Serife E.;
Mizrak, Dilsa;
Alkan, Ali;
Demirkazik, Ahmet

Publication type:

Article

Severe periocular bleeding induced by bevacizumab in a patient with recurrent glioblastoma multiforme.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 392, doi. 10.1177/1078155216643858

By:

Eryılmaz, Melek K.;
Mutlu, Hasan;
Yalçin Müsri, Fatma;
Salim, Derya K.;
Tazegül, Gökhan;
Coşkun, Hasan Ş

Publication type:

Article

Cost avoidance from dose rounding biologic and cytotoxic antineoplastics.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 379, doi. 10.1177/1078155216639756

By:

Vandyke, Thomas H.;
Athmann, Paul W.;
Ballmer, Corey M.;
Kintzel, Polly E.

Publication type:

Article

Mixed outpatient–inpatient autologous stem cell transplant for multiple myeloma: A cost-saving initiative in a resource constrained environment.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 384, doi. 10.1177/1078155216639753

By:

Clemmons, Amber B.;
Anderegg, Samm

Publication type:

Article

Safe handling of oral antineoplastic medications: Focus on targeted therapeutics in the home setting.

Published in:

Journal of Oncology Pharmacy Practice, 2017, v. 23, n. 5, p. 350, doi. 10.1177/1078155216637217

By:

Cass, Yaakov;
Connor, Thomas H.;
Tabachnik, Alexander

Publication type:

Article